Everolimus-Eluting Stents Improve Vascular Response in a Diabetic Animal Model | Zendy

Anwer Habib | Zendy; Vinit Karmali | Zendy; Michael C. John | Zendy; Rohini Polavarapu | Zendy; Gaku Nakazawa | Zendy; Kim Pachura | Zendy; Talina Davis | Zendy; Frank D. Kolodgie | Zendy; Renu Virmani | Zendy; Aloke V. Finn | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Everolimus-Eluting Stents Improve Vascular Response in a Diabetic Animal Model

Author(s) -

Anwer Habib,

Vinit Karmali,

Michael C. John,

Rohini Polavarapu,

Gaku Nakazawa,

Kim Pachura,

Talina Davis,

Frank D. Kolodgie,

Renu Virmani,

Aloke V. Finn

Publication year - 2014

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.113.001023

Subject(s) - sirolimus , everolimus , medicine , stent , diabetes mellitus , cardiology , drug eluting stent , bare metal stent , urology , zotarolimus , pharmacology , restenosis , endocrinology

Preclinical evaluation of the vascular response of drug-eluting stents is limited especially in the setting of diabetes mellitus preventing the evaluation of changes in drug-eluting stent design and eluted drugs after clinical use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research